Definium Therapeutics (DFTX) Hits New High on Impressive Drug Candidate Trial

Source Summary

Definium Therapeutics Inc. (NASDAQ:DFTX) is one of the 10 Stocks Paying Off Big Time. Definium Therapeutics saw its share prices jump to a nearly five-year high on Monday, as investors positioned their portfolios after reporting strong results from the late-stage clinical trial of its therapy candidate for major depressive disorders (MDD). In intra-day trading, the [...]